↓ Skip to main content

Relationship between treatment delay and final infarct size in STEMI patients treated with abciximab and primary PCI

Overview of attention for article published in BMC Cardiovascular Disorders, February 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Relationship between treatment delay and final infarct size in STEMI patients treated with abciximab and primary PCI
Published in
BMC Cardiovascular Disorders, February 2012
DOI 10.1186/1471-2261-12-9
Pubmed ID
Authors

Tim Tödt, Eva Maret, Joakim Alfredsson, Magnus Janzon, Jan Engvall, Eva Swahn

Abstract

Studies on the impact of time to treatment on myocardial infarct size have yielded conflicting results. In this study of ST-Elevation Myocardial Infarction (STEMI) treated with primary percutaneous coronary intervention (PCI), we set out to investigate the relationship between the time from First Medical Contact (FMC) to the demonstration of an open infarct related artery (IRA) and final scar size.Between February 2006 and September 2007, 89 STEMI patients treated with primary PCI were studied with contrast enhanced magnetic resonance imaging (ceMRI) 4 to 8 weeks after the infarction. Spearman correlation was computed for health care delay time (defined as time from FMC to PCI) and myocardial injury. Multiple linear regression was used to determine covariates independently associated with infarct size.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 5%
South Africa 1 5%
Unknown 19 90%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 19%
Unspecified 2 10%
Student > Master 2 10%
Researcher 2 10%
Student > Ph. D. Student 2 10%
Other 4 19%
Unknown 5 24%
Readers by discipline Count As %
Medicine and Dentistry 12 57%
Unspecified 2 10%
Unknown 7 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2014.
All research outputs
#7,454,951
of 22,790,780 outputs
Outputs from BMC Cardiovascular Disorders
#422
of 1,607 outputs
Outputs of similar age
#51,610
of 156,532 outputs
Outputs of similar age from BMC Cardiovascular Disorders
#4
of 12 outputs
Altmetric has tracked 22,790,780 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,607 research outputs from this source. They receive a mean Attention Score of 3.8. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,532 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.